7.4. Adjuvant intravesical treatment. Although TURB by itself can eradicate a TaT1 tumour completely, these tumours commonly recur and can progress to MIBC. The high variability in the 3-month recurrence rate indicates that the TURB was incomplete or provokes recurrences in a high percentage of patients [144]. It is therefore necessary to consider adjuvant therapy in all patients. 